• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Single-agent cladribine as an effective front-line therapy for adults with Langerhans cell histiocytosis.

作者信息

Goyal Gaurav, Abeykoon Jithma P, Hu Marie, Young Jason R, Shah Mithun V, Bennani N Nora, Call Timothy G, Hook C Christopher, Pardanani Animesh, Inwards David J, Vassallo Robert, Ryu Jay H, Tobin W Oliver, Koster Matthew J, Davidge-Pitts Caroline J, Ravindran Aishwarya, Rech Karen L, Go Ronald S

机构信息

Division of Hematology-Oncology, University of Alabama at Birmingham, Birmingham, Alabama.

Research Collaborator, Division of Hematology, Mayo Clinic, Rochester, Minnesota.

出版信息

Am J Hematol. 2021 May 1;96(5):E146-E150. doi: 10.1002/ajh.26119. Epub 2021 Feb 19.

DOI:10.1002/ajh.26119
PMID:33539584
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8044045/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ae/8044045/686f1eb38613/nihms-1686598-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ae/8044045/686f1eb38613/nihms-1686598-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ae/8044045/686f1eb38613/nihms-1686598-f0001.jpg

相似文献

1
Single-agent cladribine as an effective front-line therapy for adults with Langerhans cell histiocytosis.单药克拉屈滨作为成人朗格汉斯细胞组织细胞增多症的有效一线治疗方法。
Am J Hematol. 2021 May 1;96(5):E146-E150. doi: 10.1002/ajh.26119. Epub 2021 Feb 19.
2
Treatment of Multifocal Multisystem BRAF Positive Langerhans Cell Histiocytosis with Cladribine, Surgery and Allogenic Stem Cell Transplantation.用克拉屈滨、手术和异基因干细胞移植治疗多灶性多系统BRAF阳性朗格汉斯细胞组织细胞增多症
Acta Medica (Hradec Kralove). 2017;60(4):152-156. doi: 10.14712/18059694.2018.11.
3
How I manage pulmonary Langerhans cell histiocytosis.我如何治疗肺朗格汉斯细胞组织细胞增多症。
Eur Respir Rev. 2017 Sep 6;26(145). doi: 10.1183/16000617.0070-2017. Print 2017 Sep 30.
4
[Pulmonary manifestations of Langerhans cell histiocytosis].[朗格汉斯细胞组织细胞增多症的肺部表现]
Rev Mal Respir. 2015 Oct;32(8):850-66. doi: 10.1016/j.rmr.2015.01.005. Epub 2015 May 21.
5
Cladribine therapy in adults with advanced Langerhans cell histiocytosis.成人晚期朗格汉斯细胞组织细胞增多症的克拉屈滨治疗
Leuk Lymphoma. 2013 Jul;54(7):1541-3. doi: 10.3109/10428194.2012.744454. Epub 2012 Nov 26.
6
[A case of pituitary involvement in pediatric multifocal craniofacial Langerhans cell histiocytosis].[小儿多灶性颅面骨朗格汉斯细胞组织细胞增多症累及垂体1例]
Zhonghua Er Ke Za Zhi. 2025 Jun 2;63(6):673-675. doi: 10.3760/cma.j.cn112140-20240905-00626.
7
Cladribine (2-chlorodeoxyadenosine) in frontline chemotherapy for adult Langerhans cell histiocytosis: A single-center study of seven cases.克拉屈滨（2-氯脱氧腺苷）在前驱化疗治疗成人朗格汉斯细胞组织细胞增生症中的应用：一项单中心的七例研究。
Acta Oncol. 2013 Jun;52(5):994-1001. doi: 10.3109/0284186X.2012.716164. Epub 2012 Aug 31.
8
Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis.克拉屈滨疗法对肺朗格汉斯细胞组织细胞增多症患者的疗效。
Orphanet J Rare Dis. 2014 Nov 30;9:191. doi: 10.1186/s13023-014-0191-8.
9
Cladribine is effective against cystic pulmonary Langerhans cell histiocytosis.克拉屈滨对囊性肺朗格汉斯细胞组织细胞增多症有效。
Am J Respir Crit Care Med. 2012 Nov 1;186(9):930-2. doi: 10.1164/ajrccm.186.9.930.
10
Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.在用克拉屈滨成功治疗朗格汉斯细胞组织细胞增多症后发生的伴有眼眶和中枢神经系统受累的厄尔海姆-切斯特病。
Vojnosanit Pregl. 2016 Jan;73(1):83-7. doi: 10.2298/vsp140915037p.

引用本文的文献

1
Adolescent-and-Young-Adult-Onset Multisystem Langerhans Cell Histiocytosis With Central Nervous System Involvement: A Case Report.青少年及青年起病的多系统朗格汉斯细胞组织细胞增多症伴中枢神经系统受累：一例报告
Cureus. 2025 Aug 26;17(8):e91053. doi: 10.7759/cureus.91053. eCollection 2025 Aug.
2
[Chinese expert consensus on the diagnosis and treatment of adult Langerhans cell histiocytosis (2025)].《成人朗格汉斯细胞组织细胞增多症诊断与治疗中国专家共识（2025年版）》
Zhonghua Xue Ye Xue Za Zhi. 2025 May 14;46(5):397-401. doi: 10.3760/cma.j.cn121090-20250222-00086.
3
Characterization and treatment outcomes of malignant histiocytoses in a retrospective series of 141 cases in France.法国141例恶性组织细胞增多症回顾性系列研究的特征及治疗结果
Blood Adv. 2025 May 27;9(10):2530-2541. doi: 10.1182/bloodadvances.2024015208.
4
Current State of Targeted Therapy in Adult Langerhans Cell Histiocytosis and Erdheim-Chester Disease.成人朗格汉斯细胞组织细胞增生症和 Erdheim-Chester 病的靶向治疗现状。
Target Oncol. 2024 Sep;19(5):691-703. doi: 10.1007/s11523-024-01080-x. Epub 2024 Jul 11.
5
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures.朗格汉斯细胞组织细胞增生症：NACHO 对进展、混乱和理性治疗之路的机会的更新。
Cancer. 2024 Jul 15;130(14):2416-2439. doi: 10.1002/cncr.35301. Epub 2024 Apr 30.
6
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy.混合性组织细胞肿瘤：揭示多种体细胞突变和对靶向治疗反应的多中心系列研究。
Br J Haematol. 2024 Jul;205(1):127-137. doi: 10.1111/bjh.19462. Epub 2024 Apr 12.
7
Continuous flow biocatalysis: synthesis of purine nucleoside esters catalyzed by lipase TL IM from .连续流生物催化：来自……的脂肪酶TL IM催化嘌呤核苷酯的合成
RSC Adv. 2024 Apr 4;14(16):10953-10961. doi: 10.1039/d4ra00097h. eCollection 2024 Apr 3.
8
Phase 2 study using low dose cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis.一项使用小剂量阿糖胞苷治疗新诊断的朗格汉斯细胞组织细胞增生症成人患者的 2 期研究。
Leukemia. 2024 Apr;38(4):803-809. doi: 10.1038/s41375-024-02174-1. Epub 2024 Feb 22.
9
Outcomes after interruption of targeted therapy in patients with histiocytic neoplasms.组织细胞肿瘤患者中断靶向治疗后的结局。
Br J Haematol. 2023 Nov;203(3):389-394. doi: 10.1111/bjh.18964. Epub 2023 Jul 3.
10
Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E-positive LCH.维莫非尼联合克拉屈滨和阿糖胞苷治疗儿科 BRAF V600E 阳性朗格汉斯细胞组织细胞增生症可获得持久缓解。
Blood Adv. 2023 Sep 26;7(18):5246-5257. doi: 10.1182/bloodadvances.2022009067.

本文引用的文献

1
Spectrum of second primary malignancies and cause-specific mortality in pediatric and adult langerhans cell histiocytosis.儿童及成人朗格汉斯细胞组织细胞增多症的第二原发性恶性肿瘤谱及特定病因死亡率
Leuk Res. 2023 Mar;126:107032. doi: 10.1016/j.leukres.2023.107032. Epub 2023 Feb 6.
2
Efficacy of BRAF-Inhibitor Therapy in BRAF -Mutated Adult Langerhans Cell Histiocytosis.BRAF抑制剂疗法对BRAF突变型成人朗格汉斯细胞组织细胞增多症的疗效
Oncologist. 2020 Dec;25(12):1001-1004. doi: 10.1002/onco.13541. Epub 2020 Oct 12.
3
Long-term efficacy and safety of 2CdA (cladribine) in extra-pulmonary adult-onset Langerhans cell histiocytosis: analysis of 23 cases from the French Histiocytosis Group and systematic literature review.2CdA（克拉屈滨）治疗肺外器官发病的成人朗格汉斯细胞组织细胞增生症的长期疗效和安全性：法国组织细胞增生症研究组 23 例病例分析及系统文献复习。
Br J Haematol. 2020 Jun;189(5):869-878. doi: 10.1111/bjh.16449. Epub 2020 Mar 19.
4
Efficacy of MEK inhibition in patients with histiocytic neoplasms.MEK 抑制在组织细胞肿瘤患者中的疗效。
Nature. 2019 Mar;567(7749):521-524. doi: 10.1038/s41586-019-1012-y. Epub 2019 Mar 13.
5
Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study.维莫非尼治疗 BRAF V600 突变型 Erdheim-Chester 病和朗格汉斯细胞组织细胞增生症：来自组织学独立、开放标签 VE-BASKET 研究的数据分析。
JAMA Oncol. 2018 Mar 1;4(3):384-388. doi: 10.1001/jamaoncol.2017.5029.
6
Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study).针对54例 Erdheim-Chester病患者的靶向治疗，包括中断治疗后的随访（LOVE研究）。
Blood. 2017 Sep 14;130(11):1377-1380. doi: 10.1182/blood-2017-03-771873. Epub 2017 Jun 30.
7
Clinical and Radiologic Responses to Cladribine for the Treatment of Erdheim-Chester Disease. cladribine 治疗 Erdheim-Chester 病的临床和放射学反应。
JAMA Oncol. 2017 Sep 1;3(9):1253-1256. doi: 10.1001/jamaoncol.2017.0041.
8
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms.多样且可靶向的激酶改变驱动组织细胞肿瘤。
Cancer Discov. 2016 Feb;6(2):154-65. doi: 10.1158/2159-8290.CD-15-0913. Epub 2015 Nov 13.
9
Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis.克拉屈滨疗法对肺朗格汉斯细胞组织细胞增多症患者的疗效。
Orphanet J Rare Dis. 2014 Nov 30;9:191. doi: 10.1186/s13023-014-0191-8.
10
Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.霍奇金淋巴瘤和非霍奇金淋巴瘤初始评估、分期及反应评估的建议：卢加诺分类
J Clin Oncol. 2014 Sep 20;32(27):3059-68. doi: 10.1200/JCO.2013.54.8800.